Loader

Please wait...

Canadian Pharmacists Association
Canadian Pharmacists Association
Share
Facebook Share
Twitter Share
LinkedIn Share
Google Plus Share
Email Share

Better Pharmacare for Patients: Evaluating Policy Options

Patient-centred collaborative discussion paper aims to inform pharmacare discussion

July 23, 2018 (Ottawa): Important patient-driven principles must guide pharmacare policy, program design and administration, suggests a joint discussion paper released today by the Canadian Pharmacists Association (CPhA), Best Medicines Coalition (BMC) and Health Charities Coalition of Canada (HCCC). Better Pharmacare for Patients: Evaluating Policy Options provides a patient-led assessment of five leading policy options to improve drug access for Canadians based on the principles of equity, timeliness of access, appropriateness of therapy, affordability and sustainability.

CPhA, representing pharmacists, along with patient group representatives from the BMC and HCCC, partnered to develop this report given the unique role pharmacists play in helping patients navigate their drug plans. The organizations also share an understanding that patients have the most at stake in pharmaceutical reform. It is hoped that the information presented offers policy makers and health care stakeholders additional insights and a patient-focused lens through which to evaluate options for the implementation of pharmacare. The development of the discussion paper was informed and supported by the views and expertise of a Pharmacare Working Group, comprised of representatives from the CPhA, BMC and HCCC.